Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MA › Wareham › NPI 1205022654
Physician

Anderson, Michelle

Anderson, Michelle was paid $62K by Medicaid between Aug 2022 and Mar 2023, across 8 billing codes. Its largest line is 87637, Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV — 33% of everything it billed.

33Billing provider infoANDERSON, MICHELLE
WAREHAM, MA 02571
33aNPI1205022654assigned 09/19/2007
33bProvider typePediatrics Physician
28Total paid$62K
24GClaims963
24DCodes billed8
24AFirst – last monthAug 2022 – Mar 2023
Compared with peers

Next to other Pediatrics Physician providers in Massachusetts

Rank by total paid#467 of 1,273
Median peer was paid$24K
This provider vs. median2.6×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$5.0K$10K$15K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2022502$29K
2023461$33K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 33% 144 142 $21K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 28% 154 151 $17K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 23% 252 247 $15K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 6.0% 159 157 $4K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 5.5% 111 109 $3K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 2.8% 34 34 $2K
S0302 Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) 1.2% 82 82 $742.10
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 27 27 $277.29

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.